Status:
UNKNOWN
Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers
Lead Sponsor:
Fakultas Kedokteran Universitas Indonesia
Conditions:
Diabetic Foot Ulcer
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
Brief Summary
Diabetic foot ulcer (DFU) is a common complication of diabetes with global prevalence of 6.3%. Treatment of diabetic foot ulcer (DFU) is challenging with disappointing outcome. Wound debridement, infe...
Eligibility Criteria
Inclusion
- Patients with DFU
- Ankle brachial index (ABI) 0.9 - 1.3
- Wound area 5 - 20 cm\^2
- Wound depth until subcutaneous tissue
- Without systemic infection, osteomyelitis, septic arthritis, or fasciitis
- Subjects are willing to participate by signing consent
Exclusion
- Gangrene
- On treatment with systemic corticosteroids within 7 days before the start of study
- On treatment with systemic antibiotics within 2 days before the start of study
- Patients with end stage renal disease
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04098562
Start Date
October 1 2019
End Date
January 1 2020
Last Update
September 25 2019
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
RS Persahabatan
Jakarta, DKI Jakarta, Indonesia, 13230
2
RS Pusat Angkatan Darat Gatot Soebroto
Jakarta Pusat, DKI Jakarta, Indonesia, 10410
3
RSUPN dr. Cipto Mangunkusumo
Jakarta Pusat, DKI Jakarta, Indonesia, 10430